Protein kinase G reverses all isoproterenol induced changes of cardiac single L-type calcium channel gating

Cardiovasc Res. 2000 Dec;48(3):367-74. doi: 10.1016/s0008-6363(00)00194-2.

Abstract

Objective: cGMP reduces the effect of beta-adrenoceptor agonists on cardiac L-type calcium current by protein kinase G activation. Stimulation of beta-adrenoceptors increases protein kinase A dependent phosphorylation of L-type calcium channels via cAMP. At the single channel level, protein kinase A dependent phosphorylation increases both availability and open probability. The present study investigates how cGMP antagonises protein kinase A induced changes of single L-type calcium channel gating.

Methods: Single L-type calcium channels were recorded in the cell attached configuration of the patch clamp technique in isolated mouse ventricular myocytes.

Results: The beta-adrenoceptor agonist isoproterenol (10(-6) M) enhanced single channel peak average current by increasing availability and open probability and decreasing the time constant of long close times. 8-Br-cGMP (10(-3) M) completely reversed these effects. The phosphatase inhibitor okadaic acid (10(-6) M) did not influence the effect of 8-Br-cGMP. The protein kinase G inhibitor Rp-8Br-PET-cGMPS (10(-7) M) abated the effect of 8-Br-cGMP. Activation of protein kinase A by the hydrolysis-resistant cAMP derivative 8-Br-cAMP (10(-3) M) enhanced L-type calcium channel activity like isoproterenol and its effect was also reversed by 8-Br-cGMP.

Conclusion: 8-Br cGMP diminishes beta-adrenoceptor activation of L-type calcium channels via protein kinase G. It interacts with the beta-adrenoceptor signaling pathway distal of adenylyl cyclase. Our observations suggest that protein kinase G interacts either with protein kinase A or directly with the L-type calcium channel.

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Adrenergic beta-Agonists / pharmacology
  • Analysis of Variance
  • Animals
  • Calcium Channels, L-Type / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Cyclic GMP / analogs & derivatives*
  • Cyclic GMP / pharmacology*
  • Cyclic GMP-Dependent Protein Kinases / metabolism*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Ion Channel Gating / drug effects*
  • Isoproterenol / pharmacology
  • Male
  • Mice
  • Myocardium / metabolism*
  • Okadaic Acid / pharmacology
  • Patch-Clamp Techniques
  • Phosphoric Monoester Hydrolases / antagonists & inhibitors
  • Second Messenger Systems / physiology*

Substances

  • Adrenergic beta-Agonists
  • Calcium Channels, L-Type
  • Enzyme Inhibitors
  • Okadaic Acid
  • 8-Bromo Cyclic Adenosine Monophosphate
  • 8-bromocyclic GMP
  • Cyclic AMP-Dependent Protein Kinases
  • Cyclic GMP-Dependent Protein Kinases
  • Phosphoric Monoester Hydrolases
  • Cyclic GMP
  • Isoproterenol